373 related articles for article (PubMed ID: 16840748)
1. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.
Ryan S; Taylor CT; McNicholas WT
Am J Respir Crit Care Med; 2006 Oct; 174(7):824-30. PubMed ID: 16840748
[TBL] [Abstract][Full Text] [Related]
2. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome.
Minoguchi K; Tazaki T; Yokoe T; Minoguchi H; Watanabe Y; Yamamoto M; Adachi M
Chest; 2004 Nov; 126(5):1473-9. PubMed ID: 15539715
[TBL] [Abstract][Full Text] [Related]
3. [Association between residual sleepiness and central sleep apnea events in patients with obstructive sleep apnea syndrome].
Yao SM; Zhang XL
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Sep; 31(9):664-9. PubMed ID: 19080566
[TBL] [Abstract][Full Text] [Related]
4. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome.
Ciftci TU; Kokturk O; Bukan N; Bilgihan A
Cytokine; 2004 Oct; 28(2):87-91. PubMed ID: 15381186
[TBL] [Abstract][Full Text] [Related]
5. Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome.
Ryan S; Ward S; Heneghan C; McNicholas WT
Chest; 2007 Apr; 131(4):1100-7. PubMed ID: 17426215
[TBL] [Abstract][Full Text] [Related]
6. Impact of Continuous Positive Airway Pressure Treatment on Leptin Levels in Patients with Obstructive Sleep Apnea Syndrome.
Yosunkaya Ş; Okur HK; Can Ü; Zamani A; Kutlu R
Metab Syndr Relat Disord; 2015 Aug; 13(6):272-7. PubMed ID: 25867002
[TBL] [Abstract][Full Text] [Related]
7. Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in Obstructive Sleep Apnea Syndrome (OSAS) patients.
De Santis S; Cambi J; Tatti P; Bellussi L; Passali D
Otolaryngol Pol; 2015; 69(2):1-8. PubMed ID: 26224223
[TBL] [Abstract][Full Text] [Related]
8. CPAP Does Not Reduce Inflammatory Biomarkers in Patients With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea: A Randomized Controlled Trial.
Thunström E; Glantz H; Yucel-Lindberg T; Lindberg K; Saygin M; Peker Y
Sleep; 2017 Nov; 40(11):. PubMed ID: 29029237
[TBL] [Abstract][Full Text] [Related]
9. Relationship between serum substance P levels and daytime sleepiness in obstructive sleep apnea syndrome.
Ursavas A; Karadag M; Ilcol YO; Burgazlioglu B; Ercan I; Gozu RO
Chest; 2007 May; 131(5):1400-5. PubMed ID: 17494790
[TBL] [Abstract][Full Text] [Related]
10. [Effects of continuous positive airway pressure treatment of inflammatory factors in patients with overlap syndrome].
Wang Y; Su M; Zhang X
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(6):416-9. PubMed ID: 24754983
[TBL] [Abstract][Full Text] [Related]
11. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome.
Sugiura T; Noda A; Nakata S; Yasuda Y; Soga T; Miyata S; Nakai S; Koike Y
Respiration; 2007; 74(1):56-60. PubMed ID: 16299414
[TBL] [Abstract][Full Text] [Related]
12. Clinical, polysomnographic, and CPAP titration features of obstructive sleep apnea: Mixed versus purely obstructive type.
Lee SA; Lee GH; Chung YS; Kim WS
J Neurol Sci; 2015 Aug; 355(1-2):150-4. PubMed ID: 26066559
[TBL] [Abstract][Full Text] [Related]
13. Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome.
Sozer V; Kutnu M; Atahan E; Calıskaner Ozturk B; Hysi E; Cabuk C; Musellim B; Simsek G; Uzun H
Clin Respir J; 2018 Apr; 12(4):1615-1622. PubMed ID: 28960823
[TBL] [Abstract][Full Text] [Related]
14. Effects of nasal CPAP on exhaled SIRT1 and tumor necrosis factor-α in patients with obstructive sleep apnea.
Lin CC; Liaw SF; Chiu CH; Chen WJ; Lin MW; Chang FT
Respir Physiol Neurobiol; 2016 Jul; 228():39-46. PubMed ID: 26976689
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent inflammatory factor production and NFκB activation in a rodent model of intermittent hypoxia.
Li S; Qian XH; Zhou W; Zhang Y; Feng J; Wan NS; Zhang Z; Guo R; Chen BY
Swiss Med Wkly; 2011; 141():w13309. PubMed ID: 22143914
[TBL] [Abstract][Full Text] [Related]
16. Long-term evaluation of mental fatigue by Maastricht Questionnaire in patients with OSAS treated with CPAP.
Carratú P; Karageorgiou G; Bonfitto P; Di Gioia G; Lacedonia D; Barbaro MP; Resta O
Monaldi Arch Chest Dis; 2007 Mar; 67(1):6-9. PubMed ID: 17564278
[TBL] [Abstract][Full Text] [Related]
17. Obstructive sleep apnea syndrome and arterial hypertension--a complicated relationship? The role of controlling blood pressure values in patients with OSAS.
Deleanu OC; Mălăuţ AE; Nebunoiu AM; Micheu MM; Mihălţan FD
Pneumologia; 2014; 63(1):36-43. PubMed ID: 24800594
[TBL] [Abstract][Full Text] [Related]
18. Decreased plasma levels of orexin-A in sleep apnea.
Busquets X; Barbé F; Barceló A; de la Peña M; Sigritz N; Mayoralas LR; Ladaria A; Agustí A
Respiration; 2004; 71(6):575-9. PubMed ID: 15627867
[TBL] [Abstract][Full Text] [Related]
19. The effect of continuous positive airway pressure treatment on inflammatory parameters and periostin levels in patients with obstructive sleep apnea syndrome.
Tosun F; Babayiğit C; Dikmen N; Doğan S; Dirican E
Sleep Breath; 2023 Mar; 27(1):275-282. PubMed ID: 35478293
[TBL] [Abstract][Full Text] [Related]
20. Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea.
Can M; Uygur F; Tanrıverdi H; Acıkgoz B; Alper B; Guven B
Immunol Res; 2016 Dec; 64(5-6):1179-1184. PubMed ID: 27665460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
